002370SZSE

Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. Notice of 2025 Annual Shareholders' Meeting

✨ AI Summary

Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. announces its 2025 Annual Shareholders' Meeting to be held on May 22, 2026. The meeting will discuss 11 proposals, including the 2025 work report, financial statements, and profit distribution plan. Shareholders can attend in person or vote online.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Securities Code: 002370 Securities Abbreviation: Asia-Pacific Pharmaceutical Announcement No.: 2026-037

Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. Notice of 2025 Annual Shareholders' Meeting

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

I. Basic Information of the Meeting

  1. Session of the Shareholders' Meeting: 2025 Annual Shareholders' Meeting
  2. Convener of the Shareholders' Meeting: Board of Directors
  3. The convening and holding of this meeting comply with the "Company Law of the People's Republic of China," the "Shenzhen Stock Exchange Stock Listing Rules," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Norms for the Operation of Main Board Listed Companies," and other laws, administrative regulations, departmental rules, normative documents, and the "Articles of Association."
  4. Meeting Time:
    1. On-site Meeting Time: May 22, 2026, 14:30
    2. Online Voting Time: The specific time for online voting through the Shenzhen Stock Exchange system is May 22, 2026, 9:15-9:25, 9:30-11:30, 13:00-15:00; the specific time for voting through the Shenzhen Stock Exchange Internet Voting System is any time from May 22, 2026, 9:15 to 15:00.
  5. Meeting Method: Combination of on-site voting and online voting.
  6. Equity Registration Date: May 18, 2026
  7. Attendees:
    1. Common shareholders of the Company or their authorized representatives holding shares on the equity registration date. As of the close of business on May 18, 2026 (Monday), all common shareholders of the Company registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited are entitled to attend this shareholders' meeting and may entrust an authorized representative to attend the meeting and vote in writing. The authorized representative does not need to be a shareholder of the Company.
    2. Company directors, senior management personnel.
    3. Lawyers hired by the Company.
    4. Other personnel who should attend the shareholders' meeting in accordance with relevant laws and regulations.
  8. Meeting Location: Third-floor conference room, Company office building, No. 36 Nanbin West Road, Li Haizhen, Binhai New City, Shaoxing, Zhejiang Province.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…